Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

European Innovation Council · Running

PACT4EYE Innovative Photoactivated Ruthenium Chemotherapy to treat eye cancer

Coordinator
Universiteit Leiden, Netherlands
Runs
1 November 2023 to 31 October 2026
Status
Running
EU funding
€2.5m
Total cost
€2.5m
Partners
4 organisations in 3 countries
Type
European Innovation Council
Grant agreement
101136703

What the project is doing

In the project's own words, from its summary on CORDIS.

Uveal melanoma (UM) is a rare tumor of the eye

Topics

Who is involved

OrganisationCityCountryRole
Universiteit LeidenLeidenNetherlandsCoordinator
Institut CurieParisFranceParticipant
Recornea SRLMartignacco UdItalyParticipant
Academisch Ziekenhuis LeidenLeidenNetherlandsParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI